2′-Deoxy-2′-Fluoro-2′-C-Methyl Oligonucleotides for Gene Silencing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a need for effective nucleotides or modifications for dsRNA molecules that enhance the inhibition of target gene expression.

Innovation Solution

The development of oligonucleotides comprising 2′-geminal-substituted nucleosides, such as those described by formulas (I) and (II), which can be incorporated into dsRNA strands to improve gene silencing efficacy.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional dsRNA molecules are used for gene silencing, then gene expression inhibition can be achieved, but stability and activity are insufficient leading to reduced silencing efficiency

Engineering Contradiction:
Improvegene silencing efficiencyVSAvoiddsRNA stability
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent applies parameter changes by modifying the chemical structure of nucleosides within dsRNA molecules. Specifically, it incorporates 2′-deoxy-2′-fluoro-2′-C-methyl nucleotides (where a fluorine atom and a methyl group are added at the 2′ position of the ribose sugar) to enhance both stability and gene silencing efficiency while maintaining the functional integrity of the dsRNA structure

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs composite materials by creating hybrid nucleoside structures that combine elements from different chemical families. The 2′-deoxy-2′-fluoro-2′-C-methyl nucleotides integrate fluorinated sugar moieties with methyl group substitutions, forming composite nucleoside units that exhibit enhanced stability and activity compared to natural nucleotides

Inventive Principle:
Principle #40Composite materials

2Reliability

If conventional dsRNA molecules are used for gene silencing, then gene expression inhibition can be achieved, but off-target effects occur reducing overall efficacy

Engineering Contradiction:
Improvegene silencing efficiencyVSAvoidoff-target effects
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent applies local quality by introducing specific chemical modifications at particular positions within the dsRNA structure. The 2′-deoxy-2′-fluoro-2′-C-methyl nucleotides are incorporated at strategic locations to enhance on-target specificity and reduce off-target effects, while leaving other regions of the molecule unchanged to maintain overall functionality

Inventive Principle:
Principle #3Local quality

Data Source

PatentUS20250223588A1Oligonucleotides with 2'-deoxy-2'-f-2'-c-methyl nucleotides
Publication Date: 2025.07.10 ALNYLAM PHARMACEUTICALS INC
  • US20250223588A1 patent drawing
  • US20250223588A1 patent drawing
  • US20250223588A1 patent drawing

AI summary

The present disclosure relates generally to 2′-geminal substituted nucleosides and nucleotides, and oligonucleotides and dsRNA molecules comprising such 2′-geminal substituted nucleosides and nucleotides.